The PPARδ agonist GW501516 improves survival in a mouse model of acute liver failure induced by LPS/D-GalN, primarily by suppressing the expression of pro-inflammatory cytokines such as TNF-α, IL-6, and NOS2 in vivo. Here, TNF is linked to acute liver failure.